Ellevest Inc. Sells 2,687 Shares of Relx Plc $RELX

Ellevest Inc. cut its position in shares of Relx Plc (NYSE:RELX) by 7.7% in the second quarter, HoldingsChannel reports. The firm owned 32,373 shares of the technology company’s stock after selling 2,687 shares during the period. Ellevest Inc.’s holdings in Relx were worth $1,759,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also bought and sold shares of the company. ABC Arbitrage SA raised its position in shares of Relx by 40.1% in the 1st quarter. ABC Arbitrage SA now owns 194,197 shares of the technology company’s stock worth $9,789,000 after acquiring an additional 55,579 shares in the last quarter. Charles Schwab Investment Management Inc. raised its position in shares of Relx by 16.5% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 167,175 shares of the technology company’s stock worth $8,427,000 after acquiring an additional 23,692 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Relx by 4.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 4,072,342 shares of the technology company’s stock worth $205,287,000 after acquiring an additional 173,976 shares in the last quarter. Pandora Wealth Inc. bought a new position in shares of Relx in the 1st quarter worth $757,000. Finally, Modern Wealth Management LLC bought a new position in shares of Relx in the 1st quarter worth $278,000. 15.02% of the stock is owned by institutional investors.

Relx Stock Up 0.3%

Shares of NYSE:RELX opened at $44.30 on Wednesday. The business’s 50-day moving average is $46.18 and its 200 day moving average is $50.34. Relx Plc has a 1 year low of $43.88 and a 1 year high of $56.33. The company has a quick ratio of 0.42, a current ratio of 0.47 and a debt-to-equity ratio of 2.55.

Analysts Set New Price Targets

RELX has been the subject of several recent research reports. Wall Street Zen lowered Relx from a “buy” rating to a “hold” rating in a research report on Friday, September 5th. Weiss Ratings reissued a “buy (b)” rating on shares of Relx in a research report on Wednesday, October 8th. Morgan Stanley reissued an “overweight” rating on shares of Relx in a research report on Thursday, September 11th. Barclays reaffirmed an “overweight” rating on shares of Relx in a research report on Tuesday, October 7th. Finally, Kepler Capital Markets raised Relx from a “hold” rating to a “strong-buy” rating in a research report on Thursday, September 18th. One analyst has rated the stock with a Strong Buy rating and five have assigned a Buy rating to the company’s stock. According to MarketBeat.com, Relx has an average rating of “Buy”.

About Relx

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.